Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ADCIRCA
- A Study of Fixed Dose Combination of Macitentan/Tadalafil (10 mg/20 mg) Compared to the Reference Free Combination of Macitentan and Tadalafil in Healthy Adult Participants
- Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma
- A Study of Macitentan/Tadalafil Combination Administered a Fixed-dose Combination Formulation Compared to the Reference Free Combination of Macitentan and Tadalafil
- Acute Haemodynamic Study of TPN171H in Patients With Pulmonary Arterial Hypertension
- A Study of Macitentan and Tadalafil as a Fixed Dose Combination and the Free Combination in Healthy Adult Participants
- A 2-part Study to Investigate the Effect of Macitentan in Healthy Male Participants
- Efficacy and Safety of Combination Ambrisentan and Tadalafil in Patients With Portopulmonary Hypertension
- A Study to Compare the Macitentan-tadalafil Fixed Dose Combination Tablet Relative to the Concomitant Administration of the Reference Tablets of Macitentan and Tadalafil in Healthy Subjects
- Sagene 2014 - Parkinson's Disease and Erectile Dysfunction
- Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)
- Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure: Extent of Renal Damage
- Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure
- A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
- The Effect of Sildenafil and Tadalafil on Skeletal Muscle and Perceptual Fatigue
- Tadalafil and Sildenafil for Duchenne Muscular Dystrophy
- A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil).
- Treprostinil Combined With Tadalafil for Pulmonary Hypertension
- Aortic Stenosis and PhosphodiEsterase Type 5 iNhibition (ASPEN): A Pilot Study
- Aortic Stenosis and PhosphodiEsterase iNhibition With Aortic Valve Replacement (ASPEN-AVR): A Pilot Study
- A Study of Tadalafil in Benign Prostatic Hyperplasia
- Post Marketing Observational Study in Patients With Pulmonary Arterial Hypertension
- A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
- Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)
Clinical trials list
click for details